Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Ratner

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
Nature Biotechnology|March 11, 2008
Recombinant thrombin approvedMark Ratner
Nature Biotechnology|February 11, 2014
Setback for JAK2 inhibitorsMark Ratner
Nature Biotechnology|March 10, 2010
Resuscitated deCODE refocuses on diagnosticsMark Ratner
Nature Biotechnology|June 7, 2018
Next-generation sequencing tests to become routineMark Ratner
Nature Biotechnology|December 9, 2008
Shire dumps DynepoMark Ratner
Nature Biotechnology|September 11, 2009
Human Genome Sciences trial data wow lupus communityMark Ratner
Nature Biotechnology|May 10, 2014
Fecal transplantation poses dilemma for FDAMark Ratner
Nature Biotechnology|September 12, 2013
Amgen best-seller challenged by genericsMark Ratner
Nature Biotechnology|February 7, 2018
Approval of first tumor gene panel sends shockwaves through labsMark Ratner
Nature Biotechnology|January 11, 2018
FDA to relax grip on at-home genetic tests, but concerns lingerMark Ratner
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Nature Biotechnology|March 11, 2008
Recombinant thrombin approvedMark Ratner
Nature Biotechnology|February 11, 2014
Setback for JAK2 inhibitorsMark Ratner
Nature Biotechnology|March 10, 2010
Resuscitated deCODE refocuses on diagnosticsMark Ratner
Nature Biotechnology|June 7, 2018
Next-generation sequencing tests to become routineMark Ratner
Nature Biotechnology|December 9, 2008
Shire dumps DynepoMark Ratner
Nature Biotechnology|September 11, 2009
Human Genome Sciences trial data wow lupus communityMark Ratner
Nature Biotechnology|May 10, 2014
Fecal transplantation poses dilemma for FDAMark Ratner
Nature Biotechnology|September 12, 2013
Amgen best-seller challenged by genericsMark Ratner
Nature Biotechnology|February 7, 2018
Approval of first tumor gene panel sends shockwaves through labsMark Ratner
Nature Biotechnology|January 11, 2018
FDA to relax grip on at-home genetic tests, but concerns lingerMark Ratner
Pageof 11